Analytical Biological Services, Inc. (“ABS Bio” or “the Company”), a 3 Boomerang Capital (“3 Boomerang” or “3BC”) portfolio company and a leader in biospecimen sourcing, cell culture services, and biorepository solutions for the global pharmaceutical and biotechnology industry, has acquired Cureline, Inc. (“Cureline”), a leading provider of specimen procurement and histology services to the pharmaceutical and life sciences industries. The closing marks the Company’s first tuck-in acquisition since 3BC’s original investment in June 2024. Founded in 2003 by Olga Potapova, PhD, Cureline has provided many of the world’s leading biopharmaceutical companies with mission-critical biospecimens and services for more than 20 years.
Read the full article: ABS Bio Acquires Cureline, Broadening Access to Biospecimens & Streamlining Execution from End to End //
Source: https://www.prnewswire.com/news-releases/abs-bio-acquires-cureline-broadening-access-to-biospecimens–streamlining-execution-from-end-to-end-302653417.html